Back to search

Switzerland· 68378005

Sitagliptin-Metformin-Mepha 50/1000 mg, Filmtabletten

A metformin and sitagliptin product containing metformini hydrochloridum, sitagliptinum, registered in Switzerland by Mepha Pharma AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC A10BD07

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedSitagliptin-Metformin-Mepha 50/1000 m…ATCA10BD07REGISTER NO.68378005PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Metformin and sitagliptin is registered in 14 of 19 countries.

Countries holding a registration under ATC A10BD07 (metformin and sitagliptin), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 9 of them publish a price we can compare per daily dose

Metformin and sitagliptin · ATC A10BD07

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
metformini hydrochloridum, sitagliptinum
Manufacturer
Mepha Pharma AG
Country
Switzerland (CH)
ATC code
A10BD07
ATC class
Metformin and sitagliptin
Swissmedic category
B
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680683780050
    Blist 56 Stk
    CHF 26.75

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

3 interactions on record for metformin and sitagliptin.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Metformin and sitagliptin · interactions on record

3 records

3 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Metformin and sitagliptin in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All metformin and sitagliptin products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Jamesi, Jansitin Duo
  • Belgium · Sitagliptin/Metformin Grindeks, Sitagliptin/Metformin Sandoz
  • Bulgaria · Jansitin Duo, Metlinka 50 Mg/1000 Mg
  • Cyprus · Diabremet, Jivolar
  • Czechia · Ansifora Duo, Asigefort
  • Germany · Metformax Combi, Metsunix
  • Denmark · Glerova, Sitagliptin/Metformin "sandoz"
  • Estonia · Asigefort, Diabremet
  • Spain · Disimet, Estequen
  • Finland · Brandasit, Sitagliptin/Metformin Glenmark
  • France · Sitagliptine/Chlorhydrate De Metformine Micro Labs, Sitagliptine/Chlorhydrate De Metformine Olpha
  • United Kingdom (Northern Ireland) · Sitagliptin / Metformin Hydrochloride Macleods, Sitagliptin / Metformin Hydrochloride Macleods Pharma Uk
  • Greece · Brandasit, Co-Fineria
  • Croatia · Condias Combi, Eprocliv
  • Hungary · Ansifora Duo, Asigefort
  • Ireland · Sitagliptin And Metformin Hydrochloride Ascend, Sitagliptin/Metformin Clonmel
  • Iceland · Aps, Efficib
  • Italy · Adiabin, Diesmit
  • Liechtenstein · Efficib, Janumet
  • Lithuania · Asigefort, Eprocliv
  • Latvia · Asigefort, Eprocliv
  • Malta · Combodiab Galenicum Health, Diabremet
  • Netherlands · Eprocliv, Fordiab
  • Norway · Efficib, Janumet
  • Poland · Ansifora Duo, Asigefort
  • Portugal · Jivolar, Metformina + Sitagliptina Alter
  • Romania · Eprocliv, Jamesi
  • Sweden · Jivolar, Mifomet
  • Slovenia · Eprocliv, Jivolar
  • Slovakia · Ansifora Duo, Asigefort

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e10b1e1f-e038-4ca8-b5c1-f28d3e7c2e1e
GET /v1/drugs/e10b1e1f-e038-4ca8-b5c1-f28d3e7c2e1e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "metformini hydrochloridum 1000 mg + sitagliptinum 50 mg",
  "valid_from": "2023-05-01",
  "limitations": "[{\"description\":\"Zur Behandlung von Patienten mit einem Typ 2 Diabetes mellitus, welche mit Diät und gesteigerter körperlicher Aktivität und den bisherigen oralen Therapien und/oder Insulin nur ungenügend eingestellt werden können oder diese nicht vertragen.<br>\\n- Wenn weder mit Metformin noch mit Sitagliptin als Monotherapie eine ausreichende Kontrolle der Glykämie erreicht wird, oder bei Patienten, die bereits eine Kombination von Sitagliptin und Metformin erhalten.<br>\\n- Als Dreifachkombination in Kombination mit einem Sulfonylharnstoff, wenn durch eine Kombination von zwei der drei folgenden Wirkstoffe keine ausreichende Kontrolle der Glykämie erreicht wird: Metformin, Sitagliptin oder ein Sulfonylharnstoff.<br>\\n- In Kombination mit Insulin, wenn durch diese Massnahme keine ausreichende Kontrolle der Glykämie erreicht wird. <br>\\n<br>\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2023-05-01\"}]",
  "galenic_form": "Filmtabl 50/1000mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "2023-05-01",
  "self_retention_pct": 10
}

See everything about metformin and sitagliptin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.